GAL
Galderma Grp
Stock
Stock
ISIN: CH1335392721
Ticker: GALD
CH1335392721
GALD
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 28.04.2026
$0.352
CHART BY
Frequently asked questions
What is Galderma Grp's market capitalization?
The market capitalization of Galderma Grp is 36.71B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Galderma Grp's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Galderma Grp is 72.46. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Galderma Grp?
Galderma Grp's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.135. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Galderma Grp's stock?
Currently, 21 analysts cover Galderma Grp's stock, with a consensus target price of 232.22. Analyst ratings provide insights into the stock's expected performance.
What is Galderma Grp's revenue over the trailing twelve months?
Over the trailing twelve months, Galderma Grp reported a revenue of 4.32B.
Is Galderma Grp paying dividends?
Yes, Galderma Grp is paying dividends. The next payment is scheduled for 28.04.2026, with an expected amount of .
What is the EBITDA for Galderma Grp?
Galderma Grp's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 967.64M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Galderma Grp?
Galderma Grp has a free cash flow of 857.34M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of Galderma Grp's shares?
The free float of Galderma Grp is 176.80M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 36.71B
- EPS (TTM)
- $2.135
- Free Float
- 176.80M
- P/E ratio (TTM)
- 72.46
- Revenue (TTM)
- 4.32B
- EBITDA (TTM)
- 967.64M
- Free Cashflow (TTM)
- 857.34M
Pricing
- 1D span
- $190.03$196.85
- 52W span
- $84.99$211.96
Analyst Ratings
The price target is 232.22 and the stock is covered by 21 analysts.
Buy
17
Hold
3
Sell
1
Information
Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- CH1335392721
- Primary Ticker
- GALD
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet